Sodium–Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147

Park C.M.Thanapluetiwong S.Chen X.Oh G.Ko D.Kim D.H.Mahidol University2026-04-092026-04-092026-04-01Diabetes Care Vol.49 No.4 (2026) , 75-7601495992https://repository.li.mahidol.ac.th/handle/123456789/116013NursingMedicineSodium–Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147–151NoteSCOPUS10.2337/dci26-00082-s2.0-1050340970111935554841861128